However, in an inflammatory microenvironment, IL-6 is highly expressed by macrophages and potentially triggers STAT3 serine phosphorylation as well as its mitochondrial translocation making it an interesting future target for therapy of inflammatory bone diseases (Li et al., 2022). Here, STAT3 is linked to bone inflammation disease.